References and Notes
1a
Tomioka K.
Ando K.
Takemasa Y.
Koga K.
J. Am. Chem.
Soc.
1984,
106:
2718
1b
Georg IG.
Kant J.
Tetrahedron
Lett.
1988,
29:
403
1c
Lubell WD.
Kitamura M.
Noyori R.
Tetrahedron: Asymmetry
1991,
2:
543
1d
Bartoli G.
Cimarelli C.
Marcantoni E.
Palmieri G.
Petrini M.
J.
Org. Chem.
1994,
59:
5328
2a
Bartoli G.
Bosco M.
Cimarelli C.
Dalpozzo R.
Guercio G.
Palmieri G.
J.
Chem. Soc., Perkin Trans. 1
1993,
2081
2b
Bartoli G.
Bosco M.
Cimarelli C.
Dalpozzo R.
Palmieri G.
J.
Chem. Soc., Perkin Trans. 1
1992,
2095
2c
Bartoli G.
Bosco M.
Cimarelli C.
Dalpozzo R.
Munno GD.
Guercio G.
Palmier G.
J.
Org. Chem.
1992,
57:
6020
3a
Alberola A.
Calvo LA.
Ortega AG.
Ruiz MCS.
Yustos P.
J. Org. Chem.
1999,
64:
9493
3b
Chaaban I.
Greenhill JV.
Akhtar P.
J.
Chem. Soc., Perkin Trans. 1
1979,
1593
3c
Augusti R.
Kascheres C.
J. Org. Chem.
1993,
58:
7079
3d
Eberlin MN.
Kascheres C.
J. Org. Chem.
1988,
53:
2084
3e
Al-Omran F.
El-Khair AA.
J. Heterocycl.
Chem.
2005,
45:
307
3f
Müller A.
Maier A.
Neumann R.
Maas G.
Eur. J. Org.
Chem.
1998,
1177
3g
Bejan E.
Aït-Haddou H.
Daran JC.
Balavoine
GGA.
Eur.
J. Org. Chem.
1998,
2907
4
Eddington ND.
Cox DS.
Khurana M.
Salama NN.
Stables JP.
Harrison SJ.
Negussie A.
Taylor RS.
Tran UQ.
Moore JA.
Barrow JC.
Scott KR.
Eur. J. Med. Chem.
2003,
49
5
Azzaro M.
Geribaldi S.
Videau B.
Synthesis
1981,
880
6
Dannhardt G.
Bauer A.
Nowe U.
J.
Prakt. Chem.
1998,
340:
256
7
Boger DL.
Ishizaki T.
Wysocki JR.
Munk SA.
Kitos PA.
Suntornwat O.
J. Am. Chem. Soc.
1989,
111:
6461
8a
Baraladi PG.
Simoni D.
Manfredini S.
Synthesis
1983,
902
8b
Martin DF.
Janusonis GA.
Martin BB.
J. Am. Chem. Soc.
1961,
83:
73
8c
Ferraz HMC.
Oliceira EO.
Payret-Arrua ME.
Brandt CA.
J. Org. Chem.
1995,
60:
7357
8d
Kloek JA.
Leschinsky KL.
J.
Org. Chem.
1978,
43:
1460
8e
Soloshonok VA.
Kukhar V.
Tetrahedron
1996,
52:
6953
8f
Leflemme N.
Dallemange P.
Rault S.
Synthesis
2002,
1740
9a
Zhu G.
Chen Z.
Zhang X.
J. Org. Chem.
1999,
64:
6907
9b
Garaldi PG.
Simoni D.
Manfredini S.
Synthesis
1983,
902
9c
Marchalin S.
Kuthan J.
Collect. Czech. Chem. Commun.
1983,
48:
3112
9d
Marchalin S.
Kuthan J.
Collect. Czech. Chem. Commun.
1984,
49:
1395
10
Rodríguez H.
Reyes O.
Suarez M.
Garay HE.
Pérez R.
Cruz LJ.
Verdecia Y.
Martín N.
Seoane C.
Tetrahedron
Lett.
2002,
43:
439
11a
Saeed AAH.
J. Chem.
Eng. Data
1984,
29:
358
11b
Hauser CR.
Reynolds GA.
J.
Am. Chem. Soc.
1948,
70:
2402
11c
Coffey S.
Thomson JK.
Wilson FJ.
J. Chem. Soc.
1936,
856
12
Martin DF.
Janusonis GA.
Martin BB.
J. Am. Chem. Soc.
1961,
83:
73
13a
Hickmot PW.
Sheppard G.
J.
Chem. Soc., Perkin Trans. 1
1972,
1038
13b
Bieräugel H.
Akkerman JM.
Lapierre Armande JC.
Pandit UK.
Recl.
Trav. Chim. Pays-Bas
1976,
95:
266
13c
Gravel D.
Labelle M.
Can. J. Chem.
1985,
63:
1874
13d
Yapi AD.
Mustofa M.
Valentin A.
Chavignon O.
Teulade JC.
Mallie M.
Chapat J.-P.
Blache Y.
Chem.
Pharm. Bull.
2000,
48:
1886
14a
Naringrekar VH.
Stella VJ.
J. Pharm. Sci.
1990,
79:
138
14b
Brown RJ.
Carver FWS.
Hollingsworth BL.
J. Org. Chem.
1967,
32:
2624
14c
Brandt CA.
Da Silva ACMP.
Pancote CG.
Brito CL.
Da Silveira MAB.
Synthesis
2004,
1557
15
Das B.
Venkateswarlu K.
Majhi A.
Reddy RM.
Reddy NK.
Rao KY.
Ravikumar K.
Sridhar B.
J. Mol. Catal. A: Chem.
2006,
246:
276
16
Cartaya-Marin CP.
Henderson DG.
Soeder RW.
Synth. Commun.
1997,
27:
4275
17a
Rechsteimer B.
Texier-Boullet F.
Hamelin J.
Tetrahedron Lett.
1993,
34:
5071
17b
Braibante HTS.
Braibante MEF.
Rosso GB.
Oriques DA.
J. Braz. Chem. Soc.
2003,
14:
994
18
Valduga CJ.
Squizani A.
Braibante HS.
Braibante
MEF.
Synthesis
1998,
1019
19
Stefane B.
Polanc S.
Synlett
2004,
698
20
Texier-Bouliet F.
Synthesis
1985,
679
21
Gao Y.-H.
Zhang Q.-H.
Xu J.-X.
Synth.
Commun.
2004,
34:
909
22
Bartoli G.
Bosco M.
Locatelli M.
Marcantoni E.
Melchiorre P.
Sambri L.
Synlett
2004,
239
23
Khodaei MM.
Khosropour AR.
Kookhazadeh M.
Synlett
2004,
1980
24
Arcadi A.
Bianchi G.
Di Giuseppe S.
Marinelli F.
Green Chem.
2003,
5:
64
25
Dalpozzo R.
Nino AD.
Nardi M.
Russo B.
Procopio A.
Synthesis
2006,
1127
26
Silva FC.
De Souza MCBV.
Ferreira VF.
Sabino SJ.
Antunes OAC.
Catal.
Commun.
2004,
5:
151
27
Stefani HA.
Costa IM.
de O. Silva D.
Synthesis
2000,
1526
28
Khosropour AR.
Khodaei MM.
Kookhazadeh M.
Tetrahedron
Lett.
2004,
45:
1725
29
Khodaei MM.
Khosropour AR.
Kookhazadeh M.
Can. J. Chem.
2005,
83:
209
30
Zhang Z.-H.
Yin L.
Wang Y.-M.
Adv.
Synth. Catal.
2006,
348:
184
31
Kaupp G.
Schmeyers J.
Boy J.
Chemosphere
2001,
43:
55
32
General Procedure
for the Preparation of β-Enamino Ketones
A
mixture of the solid 1,3-dicarbonyl compound (5 mmol), amine (or
ammonium, 5 mmol), and KHSO4/SiO2 (0.136
g, weight ratio 1:1) was ground in a mortar at r.t. for the appropriate
time. After completion of the reaction as indicated by TLC, the
reaction mixture was extracted with CH2Cl2 (2 × 10
mL). The combined organic layers were dried over Na2SO4 and
concentrated under reduced pressure to give a product with high
purity. The solid product could be further purified by recrystallization
in PE (Table
[²]
,
entries 1-15) or in EtOH (Table
[³]
, entries 1-12).
3-Amino-1-phenylbut-2-en-1-one (2a)
Mp 138-140 ˚C;
lit.
[³³a]
144-145 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 2.06 (s,
3 H), 5.21 (br, 1 H, NH), 5.74 (s, 1 H), 7.39-7.45 (m,
3 H), 7.87-7.89 (m, 2 H), 10.22 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 22.92, 92.34,
127.10, 128.22, 130.83, 140.20, 162.91, 189.54.
3-Amino-1-(4-methoxyphenyl)but-2-en-1-one (2b)
[³³b]
Mp
106-108 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.04 (s, 3 H), 3.85 (s,
3 H), 5.11 (br, 1 H,NH), 5.70 (s, 1 H), 6.89-6.92 (m, 2
H), 7.85-7.88 (m, 2 H), 10.13 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 22.95, 55.36,
91.88, 113.43, 129.03, 132.90, 161.89, 162.14, 188.65.
3-Amino-1-(4-fluorophenyl)but-2-en-1-one (2c)
[³³b]
Mp
106-108 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.06 (s, 3 H), 5.21 (br,
1 H, NH), 5.67 (s, 1 H), 7.06-7.09 (m, 2 H), 7.87-7.90
(m, 2 H), 10.19 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3) δ = 22.95 91.99,
115.14 (d, J = 20
Hz), 129.39 (d, J = 9
Hz), 136.40, 136.42 163.30 (d, J = 56
Hz), 165.52, 188.08.
Ethyl
2-Amino-4-oxo-4-phenylbut-2-enoate (2d)
Mp
49-51 ˚C; lit.
[³³c]
50-51 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.41 (t,
3 H, J = 7
Hz), 4.38 (q, 2 H, J = 7
Hz), 6.04 (br, 1 H, NH), 6.67 (s, 1 H), 7.46-7.54 (m, 3
H), 7.96-9.98 (m, 2 H), 9.49 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 14.13, 62.70,
93.26, 127.45, 128.44, 131.29, 139.28, 147.49, 163.88, 191.80.
3-Aminocyclohex-2-enone (2e)
Mp
128-130 ˚C; lit.
[³³d]
133 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.97 (m,
2H), 2.29 (t, 2H, J = 6
Hz), 2.35 (t, 2H, J = 6 Hz),
4.67 (br, 2H, NH), 5.26 (s, 1H). ¹³C
NMR (125 MHz, D2O) δ = 23.89, 30.60,
36.94, 99.56, 177.00, 203.01.
3-Amino-5,5-dimethylcyclohex-2-enone (2f)
Mp 164-166 ˚C;
lit.
[³³d]
165-167 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.08 (s,
6 H), 2.16 (s, 2 H), 2.20 (s, 2 H), 4.71 (br, 2 H, NH), 5.25 (s,
1 H). ¹³C NMR (125 MHz, D2O) δ = 28.35,
32.88, 42.65, 49.86, 99.27, 163.46, 197.31.
3-Amino-1,3-diphenylprop-2-en-1-one (2g)
[³³e]
Mp
78-79 ˚C. ¹H NMR (500 MHz,
CDCl3) δ = 5.46 (br, 1 H, NH), 6.16
(s, 1 H), 7.42-7.53 (m, 6 H), 7.64-7.65 (m, 2 H),
7.94-7.96 (m, 2 H), 10.43 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3) δ = 91.93, 126.36,
127.24, 128.32, 129.06, 130.74, 131.06, 137.63, 140.36, 162.88,
190.26.
3-Amino-1-(thiophen-2-yl)but-2-en-1-one (2h)
Mp 168-170 ˚C;
lit.
[³³b]
168-170 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 2.03 (s,
3 H), 5.31 (br, 1 H,NH), 5.60 (s, 1 H), 7.05-7.56 (m, 3
H), 9.91 (br, 1 H, NH). ¹³C NMR (125
MHz, CDCl3): δ = 22.73, 92.00, 127.73,
127.87, 130.21, 146.99, 162.82, 182.21.
3-(4-Methoxyphenylamino)-1-phenylbut-2-en-1-one (3a)
[³³f]
Mp
100-102 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.07 (s, 3 H), 3.82 (s,
3 H), 5.86 (s, 1 H), 6.89-6.91 (m, 2 H), 7.10-7.12 (m,
2 H), 7.41-7.46 (m, 3 H), 7.90-7.92 (m, 2 H),
12.92 (br, 1 H, NH). ¹³C NMR (125 MHz,
CDCl3): δ = 20.27, 55.52, 93.59, 114.37,
126.64, 127.05, 128.28, 130.80, 131.46, 140.16, 157.89, 163.21,
188.47.
3-(4-Chlorophenylamino)-1-phenylbut-2-en-1-one (3b)
Mp 126-128 ˚C;
lit.
[³³g]
128-129 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 2.12 (s,
3 H), 5.91 (s, 1 H), 7.09-7.15 (m, 2 H), 7.31-7.34
(m, 2 H), 7.41-7.48 (m, 3 H), 7.90-7.92 (m, 2
H), 13.07 (br, 1 H, NH). ¹³C NMR (125
MHz, CDCl3): δ = 20.30, 94.63, 125.80,
127.01, 128.26, 129.23, 131.02, 131.15, 137.20, 139.71, 161.63,
188.88.
3-(4-Nitrophenylamino)-1-phenylbut-2-en-1-one (3c)
[³³h]
Mp
140-142 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.33 (s,
3 H),
6.04 (s, 1 H), 7.25-7.28 (m, 2 H), 7.44-7.47 (m,
2 H), 7.50-7.52 (m, 1 H), 7.88-7.93 (m, 2 H),
8.21-8.25 (m, 2 H), 13.41 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 21.18, 97.54,
122.26, 125.22, 127.30, 128.50, 131.73, 139.20, 144.13, 145.18,
159.16, 189.99.
1-Phenyl-3-(
p
-tolylamino)but-2-en-1-one (3d)
[³³i]
Mp
114-116 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.10 (s,
3 H),
2.35 (s, 3 H), 5.87 (s, 1 H), 7.05-7.07 (m, 2 H), 7.15-7.25
(m, 2 H), 7.40-7.46 (m, 3 H), 7.90-7.93 (m, 2
H), 13.03 (br, 1 H, NH). ¹³C NMR (125
MHz, CDCl3): δ = 20.38, 20.97, 93.92,
124.85, 127.06, 128.27, 129.76, 130.82, 135.72, 136.02, 140.14,
162.60, 188.48.
1-(4-Methoxyphenyl)-3-(4-methoxyphenylamino)but-2-en-1-one (3e)
[³³j]
Mp
142-143 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.05 (s, 3 H), 3.82 (s,
3 H), 3.86 (s, 3 H), 5.82 (s, 1 H), 6.88-6.94 (m, 4 H),
7.09-7.11 (m, 2 H), 7.89-7.91 (m, 2 H), 12.85
(br, 1 H, NH). ¹³C NMR (125 MHz, CDCl3): δ = 20.26,
55.36, 55.49, 93.05, 113.47, 114.31, 126.57, 128.90, 131.67, 132.81,
157.74, 161.87, 162.41, 187.62.
1-(4-Fluorophenyl)-3-(4-methoxyphenylamino)but-2-en-1-one (3f)
Mp 116-118 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 2.06 (s,
3 H), 3.82 (s, 3 H), 5.80 (s, 1 H), 6.89-6.91 (m, 2 H),
7.07-7.11 (m, 4 H), 7.90-7.93 (m, 2 H), 12.87
(br, 1 H, NH). ¹³C NMR (125 MHz, CDCl3): δ = 20.25,
55.49, 93.15, 114.37, 115.16 (d, J = 21
Hz), 126.63, 129.24 (d, J = 9
Hz), 131.35, 136.36 (d, J = 4
Hz), 157.94, 163.38 (d, J = 22
Hz), 165.47, 186.94. IR (KBr): 3440, 1599, 1543, 1515, 1496, 1462,
1436, 1328, 1251, 1198, 1105, 1031, 855, 779, 520 cm-¹.
MS (EI): m/z (%) = 286
(18), 285 (100) [M+], 284
(70), 270 (18), 190 (11), 162 (36), 147 (22), 123 (71), 108 (9),
95 (27). Anal. Calcd for C17H16FNO2:
C, 71.56; H, 5.65; N, 4.91. Found: C, 71.51; H, 5.60; N, 4.87.
Ethyl 2-(4-Nitrophenylamino)-4-oxo-4-phenylbut-2-enoate (3g)
Mp 98-99 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.22 (t,
3 H, J = 7
Hz), 4.28 (q, 2 H, J = 7
Hz), 6.67 (s, 1 H), 7.04-7.05 (m, 2 H), 7.47-7.51
(m, 2 H), 7.57-7.60 (m, 1 H), 7.97-7.99 (m, 2
H), 8.19-8.21 (m, 2 H), 11.95 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 13.83, 62.79,
101.02, 120.30, 125.09, 127.77, 128.76, 132.95, 138.10, 143.72,
145.72, 146.95, 163.64, 191.94. IR (KBr): 3441, 2981, 1373, 1619, 1585,
1510, 1337, 1281, 1226, 1163, 1108, 1051, 1016, 831, 853, 750, 591,
552, 493 cm-¹. MS (EI): m/z (%) = 341
(5), 340 (33) [M+], 339 (31),
294 (14), 268 (18), 267 (84), 236 (26), 221 (15), 105 (100), 77
(42). Anal. Calcd for C18H16N2O5: C,
63.52; H, 4.74; N, 8.23. Found: C, 63.50; H, 4.67; N, 8.14.
3-(4-Nitrophenylamino)cyclohex-2-enone (3h)
[³³k]
Mp
176-178 ˚C.¹H NMR (500 MHz,
CDCl3): δ = 2.07-2.11 (m,
2 H), 2.42 (t, 2 H, J = 7
Hz), 2.56 (t, 2 H, J = 6
Hz), 5.85 (s, 1 H), 6.83 (br, 1 H, NH), 7.26-7.29 (m, 2
H), 8.19-8.21 (m, 2 H). ¹³C
NMR (125 MHz, CDCl3): δ = 21.65, 29.82, 36.55,
103.13, 121.31, 125.32, 143.35, 144.94, 159.90, 198.94.
3-(4-Methoxyphenylamino)-5,5-dimethylcyclohex-2-enone (3i)
Mp 186-188 ˚C;
lit.
[³³l]
186-188 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.05 (s,
6 H), 2.15 (s, 2 H), 2.32 (s, 2 H), 3.78 (s, 3 H), 5.34 (s, 1 H),
6.82 (dd, 2 H, J = 2,
7 Hz), 7.04 (dd, 2 H, J = 2,
7 Hz), 7.28 (s, 1 H).¹³C NMR (125 MHz,
CDCl3): δ = 28.27, 32.76, 43.02, 50.36,
55.46, 96.96, 114.37, 126.07, 131.14, 157.46, 162.87, 197.61.
3-(2,5-Dichlorophenylamino)-5,5-dimethylcyclohex-2-enone (3j)
Mp 182-184 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.14 (s,
6 H), 2.26 (s, 2 H), 2.39 (s, 2 H), 5.61 (s, 1 H), 6.12 (br, 1 H), 7.07-7.42
(m, 3 H). ¹³C NMR (125 MHz, CDCl3): δ = 28.28, 32.89,
43.74, 50.34, 100.78, 124.56, 125.27, 125.96, 130.79, 133.30, 136.28,
158.05, 198.18. IR (KBr) 3442, 3225, 2953, 2873, 1597, 1537, 1464,
1402, 1364, 1269, 1092, 1048, 925, 893, 827, 743, 519 cm-¹.
MS (EI): m/z (%) = 285
(42), 283 (50), 268 (20), 266 (20), 227 (36), 192 (100), 164 (28).
Anal. Calcd for C14H15Cl2NO: C,
59.17; H, 5.32; N, 4.93. Found: C, 59.09; H, 5.28; N, 4.90.
1,3-Diphenyl-3-(
p
-tolylamino)prop-2-en-1-one (3k)
[³³m]
Mp
120-122 ˚C. ¹H NMR (500 MHz,
CDCl3): δ = 2.23 (s, 3 H), 6.05 (s,
1 H), 6.68-7.95 (m, 14 H), 12.90 (br, 1 H, NH). ¹³C
NMR (125 MHz, CDCl3): δ = 20.79, 96.57,
123.21, 127.22, 128.33, 128.38, 128.49, 129.31, 129.55, 131.17, 133.86,
135.94, 136.80, 139.98, 161.74, 189.43.
3-(4-Chlorophenylamino)-1-(thiophen-2-yl)but-2-en-1-one (3l)
Mp 80-82 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 2.11 (s,
3 H), 5.78 (s, 1 H), 7.06-7.61 (m, 7 H), 12.71 (br, 1 H,
NH). ¹³C NMR (125 MHz, CDCl3): δ = 20.31,
94.51, 125.74, 127.89, 128.14, 129.34, 130.66, 131.21, 137.24, 146.56,
161.33, 181.88. IR (KBr): 3441, 3095, 1623, 1562, 1481, 1418, 1373,
1381, 1229, 1093, 1031, 824, 834, 766, 722, 502
cm-¹.
MS (EI): m/z (%) = 279
(25), 278 (39), 277 (67), 276 (84), 244 (87), 111 (100), 83 (8).
Anal. Calcd for C14H12ClNOS: C, 60.54; H,
4.35; N, 5.04. Found: C, 60.50; H, 4.31; N, 5.01.
33a
Baraldi PG.
Synthesis
1983,
902
33b
Singh B.
Lesher GY.
J. Heterocycl. Chem.
1990,
27:
2085
33c
Baraldi PG.
Tetrahedron
1987,
43:
235
33d
Wang
G.-W.
Green
Chem.
2006,
8:
1080
33e
Sviridov SI.
Tetrahedron
2007,
63:
12195
33f
Simunek P.
Tetrahedron
2005,
61:
8130
33g
Boatman S.
J.
Org. Chem.
1966,
31:
1785
33h
Tan SF.
Ang KP.
Jayachandran H.
J. Chem. Soc., Perkin Trans. 2
1983,
1011
33i
Khodaei MM.
Khosropour AR.
Kookhazadeh M.
Can. J. Chem.
2005,
83:
209
33j
Lyubchanskaya VM.
Mukhanova TI.
Panisheva EK.
Alekseeva LM.
Granik VG.
Khim. Farm.
Zh.
1995,
29:
40 ; Chem. Abstr. 1995, 124, 145843
33k
Zhuo J.-C.
Magn.
Reson. Chem.
1997,
355:
311
33l
Vovk MB.
Russ. J. Org. Chem.
2007,
43:
256
33m
Bannikova YN.
Khalturina VV.
Sedegova EA.
Maslivets AN.
Russ.
J. Org. Chem.
2007,
43:
154